GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PixarBio Corp (GREY:PXRB) » Definitions » EV-to-FCF

PixarBio (PixarBio) EV-to-FCF : 0.00 (As of Jun. 20, 2024)


View and export this data going back to 2016. Start your Free Trial

What is PixarBio EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, PixarBio's Enterprise Value is $0.00 Mil. PixarBio's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2016 was $-0.15 Mil. Therefore, PixarBio's EV-to-FCF for today is 0.00.

The historical rank and industry rank for PixarBio's EV-to-FCF or its related term are showing as below:

PXRB's EV-to-FCF is not ranked *
in the Biotechnology industry.
Industry Median: 6.29
* Ranked among companies with meaningful EV-to-FCF only.

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-20), PixarBio's stock price is $1.0E-5. PixarBio's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2016 was $0.000. Therefore, PixarBio's PE Ratio for today is N/A.


PixarBio EV-to-FCF Historical Data

The historical data trend for PixarBio's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PixarBio EV-to-FCF Chart

PixarBio Annual Data
Trend Dec14 Dec15
EV-to-FCF
- -

PixarBio Quarterly Data
Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Competitive Comparison of PixarBio's EV-to-FCF

For the Biotechnology subindustry, PixarBio's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PixarBio's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PixarBio's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where PixarBio's EV-to-FCF falls into.



PixarBio EV-to-FCF Calculation

PixarBio's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=0.000/-0.149
=0.00

PixarBio's current Enterprise Value is $0.00 Mil.
PixarBio's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.15 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PixarBio  (GREY:PXRB) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

PixarBio's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1.0E-5/0.000
=N/A

PixarBio's share price for today is $1.0E-5.
PixarBio's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


PixarBio EV-to-FCF Related Terms

Thank you for viewing the detailed overview of PixarBio's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


PixarBio (PixarBio) Business Description

Traded in Other Exchanges
N/A
Address
200 Boston Avenue, Suite 1875, Medford, MA, USA, 02155
PixarBio Corp is a specialty pharmaceutical company focused on preclinical and clinical commercial development of therapeutic drug delivery systems for post-operative pain. The company's lead clinical candidate, NeuroRelease is a non-opioid / non-opiate preclinical stage product intended for the treatment of surgical pain, with planned future indications for chronic pain. NeuroRelease blocks nociceptive and neuropathic pain signals arising from temperature and pressure stimuli without affecting motor function, which is intended to allow for effective treatment without delaying post-surgical physical therapy.

PixarBio (PixarBio) Headlines